Fingerprint
Dive into the research topics of 'Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): A randomised phase 3 trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): A randomised phase 3 trial
Brian I. Rini*, Bernard Escudier, Piotr Tomczak, Andrey Kaprin, Cezary Szczylik, Thomas E. Hutson, M. Dror Michaelson, Vera A. Gorbunova, Martin E. Gore, Igor G. Rusakov, Sylvie Negrier, Yen Chuan Ou, Daniel Castellano, Ho Yeong Lim, Hirotsugu Uemura, Jamal Tarazi, David Cella, Connie Chen, Brad Rosbrook, Sinil Kim
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
1558
Scopus
citations